Porton Pharmasolutions Denmark ApS

CVR 43082671 · Private limited company (ApS) · Active · Medium risk

Porton Pharmasolutions Denmark ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. 4 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -4.0m and a net result of DKK 95k. CEO: Pavlos Kouroupis.

Bankruptcy risk for Porton Pharmasolutions Denmark ApS

2.0%
probability of bankruptcy within 12 months
Medium risk

1.4 × the average (1.41%) · higher risk than 82% of active Danish companies

Lowest riskHighest risk

Increases the risk

Equity ratio< -50% · bankruptcy rate 19.3%2.2×
Share of late annual reports50%–75% · bankruptcy rate 18.4%2.1×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Website registeredYes · bankruptcy rate 12.0%1.4×

Reduces the risk

Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Loss for the yearNo · bankruptcy rate 5.3%0.60×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Gross profit growth-30%–-10% · bankruptcy rate 6.3%0.71×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×
Qualification / emphasis of matterNo · bankruptcy rate 7.1%0.80×
Missed filing deadlines0 · bankruptcy rate 7.1%0.81×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
43082671
Status
Active
Company type
Private limited company (ApS)
Founded
(4 years)
Address
Østerbrogade 226, st. 1
2100 København Ø
Municipality
København
Industry
Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr
Share capital
DKK 4.0m
Auditor
Haamann Statsautoriseret Revisionspartnerselskab
Audit opted out
Yes

Warning signs

Annual reports filed late2 of 4
Missing annual reportNo
Negative equityYes
Equity ratio-324.5%
Current ratio24%
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address219
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 2.7mDKK 3.8m
Net profitDKK 95kDKK -1.7m
EquityDKK -4.0mDKK -4.1m
Total assetsDKK 1.2mDKK 3.5m
CashDKK 1.1m–
Short-term debtDKK 5.2m–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Haamann Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025178
1 Jan 2024 – 31 Dec 2024188 Late
1 Jan 2023 – 31 Dec 2023184 Late
18 Feb 2022 – 31 Dec 2022178

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOPavlos KouroupisCurrent
Owner (100%)Porton Pharmaceutical Chemicals GmbHCurrent
FounderPorton Pharmaceutical Chemicals GmbHCurrent

Address history (2 moves)

Østerbrogade 226, st. 1, 2100 København Ø
Damsholtevej 11, 2970 Hørsholm
Skodsborgvej 125B, 2840 Holte

Other companies at the same address

Similar companies in København

Questions and answers about Porton Pharmasolutions Denmark ApS

Has Porton Pharmasolutions Denmark ApS gone bankrupt?

No, Porton Pharmasolutions Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Porton Pharmasolutions Denmark ApS?

Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.

Who is the CEO of Porton Pharmasolutions Denmark ApS?

Pavlos Kouroupis is the CEO of Porton Pharmasolutions Denmark ApS.

Who is the auditor of Porton Pharmasolutions Denmark ApS?

Porton Pharmasolutions Denmark ApS most recently used Haamann Statsautoriseret Revisionspartnerselskab.

When was Porton Pharmasolutions Denmark ApS founded?

Porton Pharmasolutions Denmark ApS was founded on 18 February 2022.

What is the equity of Porton Pharmasolutions Denmark ApS?

Equity was DKK -4.0m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.